» Articles » PMID: 1856405

Congestive Heart Failure Symptoms in Patients with Preserved Left Ventricular Systolic Function: Analysis of the CASS Registry

Overview
Date 1991 Aug 1
PMID 1856405
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical characteristics and long-term survival of 284 patients from the Coronary Artery Surgery Study (CASS) registry data base who had moderate to severe congestive heart failure symptoms and a left ventricular ejection fraction greater than or equal to 0.45 were studied. A control group consisting of registry patients with an ejection fraction greater than or equal to 0.45 who did not have heart failure was used for comparison. Patients who had heart failure were older and more likely to be female and to have a higher incidence of hypertension, diabetes and chronic lung disease than registry patients who did not have heart failure. As a group, patients with heart failure had more severe angina and were more likely to have had a prior myocardial infarction than were registry patients without heart failure. At 6 year follow-up, 82% of patients in the heart failure group survived compared with 91% of patients in the control group (p less than 0.0001). Multivariate analysis using the Cox proportional hazards model identified the following independent predictors of mortality: regional ventricular systolic dysfunction, number of diseased coronary arteries, advanced age, hypertension, lung disease, diabetes, increased left ventricular end-diastolic pressure and heart failure symptoms. Among patients with heart failure, the 6-year survival rate of those who had three-vessel coronary artery disease was 68% compared with 92% for the group without coronary artery disease. However, the 6-year survival rate for patients with heart failure who underwent surgical revascularization of diseased coronary arteries was not significantly improved compared with that of patients treated medically.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fraction.

Seo J, Hong D, Youn T, Lee S, Choi K, Kim D Front Cardiovasc Med. 2022; 9:955731.

PMID: 36046188 PMC: 9421048. DOI: 10.3389/fcvm.2022.955731.


Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.

John J, Claggett B, Skali H, Solomon S, Cunningham J, Matsushita K J Am Heart Assoc. 2022; 11(17):e021660.

PMID: 36000416 PMC: 9496411. DOI: 10.1161/JAHA.121.021660.


Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.

Manolis A, Manolis A, Manolis T, Melita H Heart Fail Rev. 2019; 24(6):847-866.

PMID: 31147814 DOI: 10.1007/s10741-019-09804-2.


Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.

Goyal P, Paul T, Almarzooq Z, Peterson J, Krishnan U, Swaminathan R J Am Heart Assoc. 2017; 6(4).

PMID: 28356281 PMC: 5532983. DOI: 10.1161/JAHA.116.003330.


Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.

Asrar Ul Haq M, Wong C, Mutha V, Anavekar N, Lim K, Barlis P World J Cardiol. 2014; 6(2):67-76.

PMID: 24575173 PMC: 3935061. DOI: 10.4330/wjc.v6.i2.67.